[In vitro study of 6B11GM to induce cellular immunity in patients with ovarian carcinoma].
OBJECTIVE: In order to explore the possibility of ovarian carcinoma anti-idiotypic single chain antibody (6B11scFV) and human granueocyte-macrophage colony stimulating factor (hGM-CSF) fusion protein 6B11GM as tumor vaccine. METHODS: Mononuclear cells, T cells and monocyte used as antigen presenting cell (APC) were separated from peripheral blood, and tumor cells were obtained from ascitic fluid in the same patients. In vitro T cell proliferation and autologous tumor cell cytotoxicity assay were applied. RESULTS: 6B11GM could induce T cell proliferation in vitro which was antigen specific. Cytotoxicity of mononuclear cells to autologous tumor cells increased after primed with 6B11GM. CONCLUSION: 6B11GM could induce efficient cellular immunity in patients with ovarian carcinoma, hopefully may be used for ovarian carcinoma vaccine.